MENU
SGMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sangamo Therapeutics (SGMO) Ownership - Who owns Sangamo Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
227.43M
P/E Ratio
N/A
Total Cash
39.2M
Projected Growth
N/A
Total Debt
27.73M
Revenue
52.29M
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash/Share
0.19
Total Debt/Equity
N/A
Revenue/Share
0.27 USD as % of share price
Fundamentals
SGMO
Capitalization
227M
P/E Ratio
N/A
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash
39.2M
Total Cash/Share
0.19
Total Debt
27.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.27%
Revenue
52.3M
ROE
N/A
Book Value
39.1M
P/B Ratio
5.81
Cash Flow
N/A
Earnings
-0.71
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.09M
Current Ratio
1.35
Current Revenue Per Employee
122004.94
Dividends Per Share - Security
N/A
EBITDA
-123.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-81.48
Shares Held By Institutions
71.8M
Shares Outstanding - Current
209M
Total Liabilities
72.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
6.863
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of transcription factors in the regulation of genes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com